{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T15:41:28Z","timestamp":1781624488601,"version":"3.54.5"},"reference-count":18,"publisher":"BMJ","issue":"Suppl 4","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Sex Transm Infect"],"accepted":{"date-parts":[[2013,9,22]]},"published-print":{"date-parts":[[2013,12]]},"abstract":"<jats:p>Although the key focus of this supplement is related to antimicrobial resistance (AMR) in a sexually transmitted infection,<jats:italic>Neisseria gonorrhoeae<\/jats:italic>, the purpose of this article is to highlight the wider public health impact of AMR and the need for different disciplines of health to coordinate and collaborate in their selection and use of antimicrobial agents. AMR is being detected in health areas ranging from simple drugs used to treat common bacterial infections to the complex formulations used to treat tuberculosis, malaria and HIV infection, and on all continents. Tackling and containing AMR present an ordeal to international and national health authorities on many fronts. In June 2012, WHO launched the WHO Global Action Plan to Control the Spread and Impact of Antimicrobial Resistance in<jats:italic>Neisseria gonorrhoeae<\/jats:italic>with a vision to enhance the global response to the prevention, diagnosis and control of<jats:italic>N gonorrhoeae<\/jats:italic>infection and mitigate the health impact of AMR through enhanced, sustained, evidence-based and collaborative multisectoral action. This global action plan is positioned within a long-standing commitment of WHO to the issue of AMR with the launch of the Global Strategy on AMR in 2001 and World Health Day on AMR in 2011.<\/jats:p>","DOI":"10.1136\/sextrans-2012-050910","type":"journal-article","created":{"date-parts":[[2013,11,8]],"date-time":"2013-11-08T04:34:28Z","timestamp":1383885268000},"page":"iv57-iv59","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":13,"title":["Moving forward in tackling antimicrobial resistance: WHO actions"],"prefix":"10.1136","volume":"89","author":[{"given":"Manjula","family":"Lusti-Narasimhan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmem L","family":"Pessoa-Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marleen","family":"Temmerman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2013,11,7]]},"reference":[{"key":"2024051410041306000_89.Suppl_4.iv57.1","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkq289"},{"key":"2024051410041306000_89.Suppl_4.iv57.2","doi-asserted-by":"publisher","DOI":"10.1086\/377500"},{"key":"2024051410041306000_89.Suppl_4.iv57.3","doi-asserted-by":"crossref","first-page":"pii: 19721","DOI":"10.2807\/ese.15.47.19721-en","article-title":"Two cases of verified clinical failures using internationally recommended first-line cefixime for gonorrhoea treatment, Norway, 2010","volume":"15","author":"Unemo","year":"2010","journal-title":"Euro Surveill"},{"key":"2024051410041306000_89.Suppl_4.iv57.4","doi-asserted-by":"publisher","DOI":"10.1099\/jmm.0.007641-0"},{"key":"2024051410041306000_89.Suppl_4.iv57.5","doi-asserted-by":"crossref","first-page":"pii = 19792","DOI":"10.2807\/ese.16.06.19792-en","article-title":"Ceftriaxone treatment failure of pharyngeal gonorrhea verified by international recommendations, Sweden, July 2010","volume":"16","author":"Unemo","year":"2011","journal-title":"Euro Surveill"},{"key":"2024051410041306000_89.Suppl_4.iv57.6","unstructured":"WHO Global strategy for containment of antimicrobial resistance. Geneva: WHO, 2001. http:\/\/whqlibdoc.who.int\/hq\/2001\/WHO_CDS_CSR_DRS_2001.2.pdf"},{"key":"2024051410041306000_89.Suppl_4.iv57.7","unstructured":"WHO World Health Assembly Resolution WHA51.17, May 1998\u2014Emerging and other communicable diseases: antimicrobial resistance. http:\/\/apps.who.int\/gb\/archive\/pdf_files\/WHA51\/ea9.pdf; WHA58.27, May 2005\u2014Improving the containment of antimicrobial resistance. http:\/\/apps.who.int\/gb\/ebwha\/pdf_files\/WHA58-REC1\/english\/Resolutions.pdf ."},{"key":"2024051410041306000_89.Suppl_4.iv57.8","unstructured":"http:\/\/www.who.int\/hiv\/topics\/drugresistance\/en\/index.html ."},{"key":"2024051410041306000_89.Suppl_4.iv57.9","unstructured":"http:\/\/www.who.int\/malaria\/areas\/drug_resistance\/en\/index.html ."},{"key":"2024051410041306000_89.Suppl_4.iv57.10","unstructured":"http:\/\/www.who.int\/tb\/challenges\/mdr\/xdr\/en\/index.html ."},{"key":"2024051410041306000_89.Suppl_4.iv57.11","unstructured":"http:\/\/www.who.int\/foodborne_disease\/resistance\/en\/index.html ."},{"key":"2024051410041306000_89.Suppl_4.iv57.12","unstructured":"WHO World Health Day 2011: Policy briefs. http:\/\/www.who.int\/world-health-day\/2011\/policybriefs\/en\/ ."},{"key":"2024051410041306000_89.Suppl_4.iv57.13","unstructured":"WHO EMRO EM\/RC49\/R.10, 2002\u2014Antimicrobial resistance and rational use of antimicrobial agents http:\/\/applications.emro.who.int\/docs\/em_rc49_r10_en.pdf. WHO SEARO, SEA\/RC63\/R4, September 2010\u2014Prevention and containment of antimicrobial resistance. http:\/\/www.searo.who.int\/LinkFiles\/RC_63_sea-rc63-r4.pdf. WHO EURO, EUR\/RC61\/R6, September 2011\u2013European strategic action plan on antibiotic resistance. http:\/\/www.euro.who.int\/__data\/assets\/pdf_file\/0014\/150611\/RC61_Res_06.pdf. WHO WPRO, WPR\/RC62.R3, October 2011\u2014Antimicrobial Resistance. http:\/\/www.wpro.who.int\/rcm\/en\/rc62\/rc_resolutions\/WPR_RC62_R3.htm ."},{"key":"2024051410041306000_89.Suppl_4.iv57.14","unstructured":"AMR as one of the 3 topics selected as entry points for addressing health risks of global concern at the human, animal and ecosystem interface: High-Level Technical Meeting to Address Health Risks at the Human-Animal Ecosystems Interfaces\u2014Meeting report FAO\u2014OIE\u2014WHO. http:\/\/un-influenza.org\/files\/HLTM-final-report.pdf ."},{"key":"2024051410041306000_89.Suppl_4.iv57.15","unstructured":"WHO. Technical consultation on strategies for global antimicrobial resistance surveillance. http:\/\/www.who.int\/drugresistance\/activities\/amr_surveillance2012\/en\/index.html"},{"key":"2024051410041306000_89.Suppl_4.iv57.16","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjmed.2006.03.013"},{"key":"2024051410041306000_89.Suppl_4.iv57.17","doi-asserted-by":"publisher","DOI":"10.1128\/CMR.00081-09"},{"key":"2024051410041306000_89.Suppl_4.iv57.18","unstructured":"World Health Organization. Global action plan to control the spread and impact of antimicrobial resistance in Neisseria gonorrhoeae. Geneva: World Health Organization, 2012. ISBN: 978 92 4 150350 1."}],"container-title":["Sexually Transmitted Infections"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/sextrans-2012-050910","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,14]],"date-time":"2024-05-14T17:04:57Z","timestamp":1715706297000},"score":1,"resource":{"primary":{"URL":"https:\/\/sti.bmj.com\/lookup\/doi\/10.1136\/sextrans-2012-050910"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,11,7]]},"references-count":18,"journal-issue":{"issue":"Suppl 4","published-online":{"date-parts":[[2013,11,15]]},"published-print":{"date-parts":[[2013,12]]}},"alternative-id":["10.1136\/sextrans-2012-050910"],"URL":"https:\/\/doi.org\/10.1136\/sextrans-2012-050910","relation":{},"ISSN":["1368-4973","1472-3263"],"issn-type":[{"value":"1368-4973","type":"print"},{"value":"1472-3263","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,11,7]]}}}